2m 2m 2m 2m 2m 2m 2m
CERVOMED (CRVO)
NASDAQ
$2.57-$0.005 (-0.19%)
Price as of Sep 11, 2026 7:30 PM EDT- $38.9MMarket Cap
- -70.96%1-Year Change
- BiotechnologyIndustry
CERVOMED (CRVO)
$2.57-$0.005 (-0.19%)
CRVO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.57 | ||
Change | +$0.09 (+3.63%) | ||
Open | $2.54 | ||
High | $2.64 | ||
Low | $2.50 | ||
Previous Close | $2.48 | ||
Volume | 234,572 | ||
30-Day Average Volume | 259,626 | ||
1-Week Change | 0.39% | ||
1-Month Change | -16.83% | ||
1-Year Change | -70.96% | ||
3-Year Change | -51.51% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 15.1M | ||
Total Assets | $26.0M | ||
Market Cap | $38.9M | ||
Enterprise Value | $16.4M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$6.6M | ||
Free Cash Flow | -$6.9M | ||
EBIT | -$6.6M | ||
EBITDA | -$6.6M | ||
Net Working Capital | $25.3M | ||
EPS | -$0.64 | ||
Enterprise Value/EBITDA | -2 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -4 | ||
PEG | -0 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 50 | ||
Last Split Date | 04/19/2022 | ||
Earnings & Revenue